Novartis Pharmaceuticals Corporation

COSENTYX

Manufacturer:

Novartis Pharmaceuticals Corporation

Cosentyx HCPCS:

C9166

HCPCS Code Descriptor:

Injection, secukinumab, intravenous, 1 mg

Category:

C Code

Cosentyx NDCs:

00078-1168-61

Primary Type:

Anti-TNF

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Cosentyx:

COSENTYX is aligned to the C Code: C9166. COSENTYX is an Anti-TNF medication produced by Novartis Pharmaceuticals Corporation and administered via the Intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

C9166 Added Date:

4/1/24

C9166 Effective Date:

4/1/24

C9166 Deactive Date:

HCPCS Active

Cosentyx billing and coding information can be found through Novartis Pharmaceuticals Corporation at the link below:
Cosentyx patient assistance information can be found through Novartis at the URL: https://www.cosentyx.com/all/cosentyx-connect-personal-support-program
COSENTYX prescribing information can be found at the link below:
Information regarding COSENTYX’s potential side effects can be found at MedlinePlus